Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercebiotech.com
FierceBiotech
Get the latest updates from FierceBiotech directly as they happen.
Follow now 327 followers
Latest posts
Last updated about 10 hours ago
How Mirum is Advancing Rare Disease Care Through Strategic M&A
about 10 hours ago
Mirum Pharmaceuticals is applying a disciplined rare disease strategy to build a...
Formation Bio’s China shopping spree continues with $500M biobucks autoimmune pact
about 11 hours ago
AI-fueled Formation Bio has inked another licensing deal for a China asset...
Belgium biotech Agomab outlines up to $212M Nasdaq debut to fund immunology trials
about 13 hours ago
Immunology biotech Agomab Therapeutics is seeking to raise up to $212.5 million...
Sanofi abandons attempt to develop next-gen mRNA seasonal flu vaccine
about 14 hours ago
Two and a half years after Sanofi unveiled to investors a revamped...
Roche diagnostics business nudges up 2% in '25 as China headwinds buffet Asia-Pacific sales
about 15 hours ago
Full-year sales for Roche’s diagnostics division were up by just 2% as...
Roche drops $100M Kiniksa fibrosis drug from phase 2 pipeline as part of quarterly clearout
about 16 hours ago
Roche has waved goodbye to a inflammation drug from Kiniksa—as well as...
Repertoire adds Lilly to range of Big Pharma partners in autoimmune deal worth up to $2.69B
about 17 hours ago
With three Big Pharma collaborations already under its belt, Flagship Pioneering spinout...
AstraZeneca vows $15B China investment to boost cell therapy and radioconjugate capabilities
about 18 hours ago
AstraZeneca has outlined plans to invest $15 billion in China through 2030...
Sanofi keeps mum on future of disappointing Denali pact after scrapping final RIPK1 inhibitor
about 18 hours ago
Sanofi is tight-lipped about the future of its underwhelming pact with Denali...
The new rules of biopharma M&A: 4 trends driving dealmaking this year
1 day ago
As biopharma M&A activity ramps back up, strategy is shifting to no...
Eikon sets $274M goal for upcoming stock market debut
1 day ago
After announcing plans to go public at the top of the year...
Halozyme catches M&A wave to snap up Surf Bio in delivery tech deal worth up to $400M
1 day ago
Shortly after acquiring Elektrofi to beef up its subcutaneous drug delivery offerings...